Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 8593-8593 ◽  
Author(s):  
P. M. Voorhees ◽  
R. F. Manges ◽  
P. Sonneveld ◽  
G. Somlo ◽  
S. Jagannath ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Refractory Multiple Myeloma

scholarly journals Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results

Neoplasma ◽  
2012 ◽  
Vol 59 (04) ◽  
pp. 440-449 ◽  
Author(s):  
L. ZAHRADOVA ◽  
K. MOLLOVA ◽  
D. OCADLIKOVA ◽  
L. KOVAROVA ◽  
Z. ADAM ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Dendritic Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Efficacy And Safety ◽  
Study Results ◽  
Id Protein

A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191

2015 ◽  
Vol 57 (6) ◽  
pp. 1463-1466 ◽  
Author(s):  
Annette E. Hay ◽  
Alli Murugesan ◽  
Ashley M. DiPasquale ◽  
Tom Kouroukis ◽  
Irwindeep Sandhu ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Clinical Trials ◽  
Phase Ii ◽  
Kinase Inhibitor ◽  
Phase Ii Study ◽  
Aurora Kinase ◽  
Aurora Kinase Inhibitor ◽  
Refractory Multiple Myeloma

Results of an ongoing open-label, phase II study of carfilzomib in patients with relapsed and/or refractory multiple myeloma (R/R MM).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 8000-8000 ◽  
Author(s):  
R. Vij ◽  
D. S. Siegel ◽  
J. L. Kaufman ◽  
A. J. Jakubowiak ◽  
A. K. Stewart ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Open Label ◽  
Refractory Multiple Myeloma ◽  
Open Label Phase

Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma

2012 ◽  
Vol 53 (9) ◽  
pp. 1722-1727 ◽  
Author(s):  
Massimo Offidani ◽  
Claudia Polloni ◽  
Federica Cavallo ◽  
Anna Marina Liberati ◽  
Stelvio Ballanti ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Refractory Multiple Myeloma

Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma

2005 ◽  
Vol 29 (10) ◽  
pp. 1233-1234 ◽  
Author(s):  
Eric H. Kraut ◽  
Donn Young ◽  
Sherif Farag ◽  
Arthur G. James ◽  
Richard J. Solove
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Refractory Multiple Myeloma

Phase II study of carboplatin (CBDCA) in refractory multiple myeloma

1994 ◽  
Vol 12 (1) ◽  
pp. 53-55 ◽  
Author(s):  
Bart Barlogie ◽  
John Crowley ◽  
Sydney E. Salmon ◽  
John Bonnet ◽  
James K. Weick ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Refractory Multiple Myeloma
Sign in / Sign up

Export Citation Format

Share Document